Suppr超能文献

同时性肾透明细胞癌和原发性肝透明细胞癌:一例报告。

Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report.

作者信息

Jiang Hua, Zhao Shanchao, Li Ganhong

机构信息

Department of Urology, The Fifth Affiliated Hospital of Zunyi Medical University, Zhuhai.

Department of Urology, Nanfang Hospital, Southern Medical University/The First School of Clinical Medicine, Southern Medical University, Guangzhou.

出版信息

Medicine (Baltimore). 2020 Nov 20;99(47):e23263. doi: 10.1097/MD.0000000000023263.

Abstract

RATIONALE

Double primary clear cell carcinomas of the liver (PCCCL) and kidney are extremely rare; moreover, there have been no reported cases of adrenal metastasis from primary clear cell tumors of the liver.

PATIENT CONCERNS

A 47-year-old male patient was admitted to our clinic with space-occupying lesions in the left kidney and liver during a regular medical examination.

DIAGNOSES

The tumors in the kidney and liver were diagnosed as primary clear cell carcinoma by histopathological examination.

INTERVENTIONS

The patient subsequently underwent nephron-sparing surgery of the left kidney and radical partial excision of the right liver lobe by laparoscopic surgery. Transcatheter arterial chemoembolization (TACE) was performed for the patient 2 weeks after tumor resection. One month after the operation, the patient started adjuvant therapy with sorafenib (400 mg twice per day orally). However, follow-up CT imaging revealed a solid mass measuring 1.9 × 2.0 × 2.0 cm in the right adrenal gland at 2 months postoperatively, and then the patient underwent radiofrequency ablation (RFA) for the right adrenal tumor.

OUTCOMES

The patient remained cancer free for 2 years following the diagnosis despite early right adrenal metastasis.

LESSONS

Hepatocyte immunostaining is sufficient for the diagnosis of PCCCL.

摘要

理论依据

肝脏和肾脏的双原发性透明细胞癌(PCCCL)极为罕见;此外,尚无原发性肝脏透明细胞瘤发生肾上腺转移的病例报道。

患者情况

一名47岁男性患者在定期体检时因左肾和肝脏占位性病变入住我院。

诊断

肾脏和肝脏的肿瘤经组织病理学检查诊断为原发性透明细胞癌。

干预措施

患者随后接受了左肾保留肾单位手术及腹腔镜下右肝叶根治性部分切除术。肿瘤切除术后2周对患者进行了经动脉化疗栓塞术(TACE)。术后1个月,患者开始口服索拉非尼(400mg,每日2次)进行辅助治疗。然而,术后2个月的随访CT影像显示右肾上腺有一个大小为1.9×2.0×2.0cm的实性肿块,随后患者接受了右肾上腺肿瘤的射频消融术(RFA)。

结果

尽管早期出现右肾上腺转移,但诊断后患者2年无癌。

经验教训

肝细胞免疫染色足以诊断PCCCL。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4259/7676612/717032e5840b/medi-99-e23263-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验